Isabel Hubbard was an Associate Scientist II at the Center for Genomics of Neurodegenerative Disease (CGND). Prior to joining the NYGC, she was a development scientist at a clinical reference laboratory, where she developed targeted oncology assays for the Illumina MiSeqDx and Ion PGM NGS platforms for use in patient molecular diagnostics. Isabel received a BS in Biological Sciences-Neuroscience Track from Carnegie Mellon University in 2013 and an MSc in Biomedical Sciences from University College London in 2014, where her thesis work involved investigating the underlying molecular and genetic pathways of the neuronal ceroid lipofuscinoses (NCLs), a group of early onset neurodegenerative disorders, under the supervision of Dr. Sara Mole at the MRC Laboratory for Molecular Cell Biology.